IRIS
DE LUCA, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.361
NA - Nord America 8.200
AS - Asia 4.993
SA - Sud America 1.347
AF - Africa 118
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 3
Totale 23.036
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.041
IE - Irlanda 2.795
SG - Singapore 1.519
DE - Germania 1.500
HK - Hong Kong 1.126
UA - Ucraina 1.109
CN - Cina 1.083
BR - Brasile 1.033
SE - Svezia 1.029
RU - Federazione Russa 728
VN - Vietnam 660
FI - Finlandia 545
IN - India 219
IT - Italia 202
GB - Regno Unito 135
AR - Argentina 123
FR - Francia 105
CA - Canada 88
ID - Indonesia 78
KR - Corea 63
MX - Messico 55
IR - Iran 50
EC - Ecuador 48
ZA - Sudafrica 46
BD - Bangladesh 41
CO - Colombia 41
PL - Polonia 41
PY - Paraguay 40
NL - Olanda 31
AT - Austria 28
ES - Italia 27
IQ - Iraq 25
JP - Giappone 24
VE - Venezuela 24
BE - Belgio 18
TR - Turchia 18
CL - Cile 17
MA - Marocco 17
PK - Pakistan 17
CZ - Repubblica Ceca 16
LT - Lituania 13
EU - Europa 12
TN - Tunisia 12
RO - Romania 11
KZ - Kazakistan 10
SA - Arabia Saudita 10
PE - Perù 9
UY - Uruguay 9
BJ - Benin 8
EG - Egitto 8
AE - Emirati Arabi Uniti 7
KE - Kenya 7
JO - Giordania 6
UZ - Uzbekistan 6
NP - Nepal 5
RS - Serbia 5
DZ - Algeria 4
IL - Israele 4
LB - Libano 4
AL - Albania 3
AZ - Azerbaigian 3
BW - Botswana 3
BY - Bielorussia 3
GR - Grecia 3
HU - Ungheria 3
JM - Giamaica 3
NG - Nigeria 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
BG - Bulgaria 2
CG - Congo 2
ET - Etiopia 2
GA - Gabon 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
KG - Kirghizistan 2
KW - Kuwait 2
MY - Malesia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BO - Bolivia 1
CR - Costa Rica 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GY - Guiana 1
KH - Cambogia 1
LU - Lussemburgo 1
LV - Lettonia 1
MW - Malawi 1
PR - Porto Rico 1
PT - Portogallo 1
Totale 23.031
Salva come PNG Salva come JPEG
Città #
Dublin 2.795
Jacksonville 1.914
Hong Kong 1.125
Dearborn 1.051
Wilmington 701
Singapore 547
Beijing 444
Ashburn 411
Lawrence 382
Princeton 382
Moscow 289
San Mateo 261
Chandler 254
Ho Chi Minh City 241
Los Angeles 212
Ann Arbor 168
Bremen 165
Andover 163
Buffalo 151
Hanoi 120
São Paulo 99
Hefei 73
Redondo Beach 70
Houston 68
Düsseldorf 67
Nanjing 64
Seoul 63
New York 60
Norwalk 54
Woodbridge 51
Kunming 50
Munich 49
Rio de Janeiro 41
Dallas 40
Piemonte 40
Tianjin 38
Leawood 36
Fairfield 35
Jinan 35
Helsinki 33
Monmouth Junction 33
Denver 32
Haiphong 32
Nuremberg 30
Warsaw 30
Toronto 29
Johannesburg 28
Guangzhou 27
Montreal 26
Santa Clara 25
Seattle 25
Biên Hòa 23
Tokyo 23
Ardabil 22
Da Nang 21
Poplar 21
Chennai 20
Torino 20
Frankfurt am Main 19
Mexico City 19
Nanchang 19
Stockholm 19
Brussels 18
London 18
Orem 18
Quito 17
Atlanta 16
Brno 16
Bắc Ninh 16
Campinas 16
Dong Ket 16
Hebei 16
Brasília 15
Guarulhos 15
Guayaquil 15
Belo Horizonte 14
Chicago 14
Jakarta 14
Manchester 14
Phoenix 14
Ribeirão Preto 14
Shenyang 14
Bexley 13
Boardman 13
Boston 13
Brooklyn 13
Xian 13
Amsterdam 12
Buenos Aires 12
Curitiba 12
Salvador 12
San Francisco 12
Zanjan 12
Bogotá 11
Bắc Giang 11
Fuzhou 11
Ninh Bình 11
Ottawa 11
Sorocaba 11
Thái Bình 11
Totale 13.909
Salva come PNG Salva come JPEG
Nome #
Impact of gender difference on vitamin D status and its relationship with the extent of coronary artery disease 116
Association between high-residual platelet reactivity in patients receiving dual antiplatelet therapy, Vitamin D plasma levels and Vitamin D Binding Protein rs7041 polymorphism. 112
Platelet PIA1/PIA2 polymorphism and the risk of periprocedural myocardial infarction in patients with acute coronary syndromes undergoing coronary angioplasty. 108
Analysis of beta1 and beta2-adrenergic receptors polymorphism in patients with apical ballooning cardiomyopathy 107
Mean platelet volume is not associated with platelet reactivity and the extent of coronary artery disease in diabetic patients 106
P2Y12 inhibitors: pharmacologic mechanism and clinical relevance 105
ACC/AHA and ESC guidelines 104
Combination between mean platelet volume and platelet distribution width to predict the prevalence and extent of coronary artery disease: results from a large cohort study 104
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease. 104
Coronary intravascular ultrasound (IVUS): Contemporary applications and bases for the future 103
Impact of Long-Term Dual Antiplatelet Therapy on Immature Platelet Count and Platelet Reactivity 103
Bivalirudin as compared to unfractionated heparin among patients undergoing coronary angioplasty A meta-analyis of randomised trials 102
Switching from clopidogrel to prasugrel in patients having coronary stent implantation. 100
PCI techniques 100
Paclitaxel-eluting versus bare metal stents in primary PCI: a pooled patient-level meta-analysis of randomized trials. 99
Aspirin desensitization in patients undergoing planned or urgent coronary stent implantation. A single-center experience. 99
Acetylsalicylic acid desensitization in patients with coronary artery disease: A comprehensive overview of currently available protocols 99
Optical coherence tomography for guidance of treatment of in-stent restenosis with cutting balloons. 97
ANMCO/SICI-GISE paper on antiplatelet therapy in acute coronary syndrome 96
Cytokines release inhibition from activated monocytes, and reduction of in-stent neointimal growth in humans 96
Neutrophil to Lymphocyte Ratio and the Extent of Coronary Artery Disease: Results from a Large Cohort Study 96
Impact of age on mean platelet volume and its relationship with coronary artery disease: A single-centre cohort study 96
Impact of hypertension on clinical outcome in STEMI patients undergoing primary angioplasty with BMS or DES: insights from the DESERT cooperation. 96
Diabetes mellitus, glucose control parameters and platelet reactivity in ticagrelor treated patients 95
Association between high-residual platelet reactivity in patients receiving dual antiplatelet therapy, Vitamin D plasma levels and Vitamin D Binding Protein rs7041 polymorphism. 95
Apical-sparing Tako-tsubo: A case report 94
Mechanical reperfusion for STEMI: from randomized trials to clinical practice 94
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor. 94
Impact of long-term dual antiplatelet therapy on immature platelet count and platelet reactivity. 94
Body Mass Index and Platelet Reactivity During Dual Antiplatelet Therapy With Clopidogrel or Ticagrelor 94
Adjuncitve pharmacotherapy: Anticoagulation 93
Impact of duration of clopidogrel prescription on outcome of DES as compared to BMS in primary angioplasty: a meta-regression analysis of randomized trials 93
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor: Reply 93
Association between high-residual platelet reactivity in patients receiving dual antiplatelet therapy, Vitamin D plasma levels and Vitamin D Binding Protein rs7041 polymorphism. 92
Antithrombotic therapies in primary angioplasty:rationale, results and future directions 91
Relationship Between Glycoprotein IIIa Platelet Receptor Gene Polymorphism and Coronary Artery Disease 91
Impact of multivessel disease on myocardial perfusion and survival among patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitors. 90
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor 90
Absolute eosinophils count and the extent of coronary artery disease: a single centre cohort study. 89
Randomized evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: Rationale and design of the REDUCE trial 89
Impact of Preprocedural TIMI Flow on Myocardial Perfusion, Distal Embolization and Mortality in Patients with ST-Segment Elevation Myocardial Infarction Treated by Primary Angioplasty and Glycoprotein IIb/IIIa Inhibitors 89
Pharmacological facilitation in primary angioplasty: myth or reality? 88
Old and New Drugs for Treatment of Stable Angina: New Anti-Anginal Drugs and Coronary Revascularization. 88
Direct coronary stenting: Effects on coronary blood flow, immediate and late clinical outcome 87
An unusual case of ECG ST-segment elevation 87
Impact of diabetes on neutrophil-to-lymphocyte ratio and its relationship to coronary artery disease 87
Immature platelet fraction and the extent of coronary artery disease: a single centre study. 87
Impact of adenosine A2a receptor polymorphism rs5751876 on platelet reactivity in ticagrelor treated patients 87
Impact of advanced age on myocardial perfusion, distal embolization, and mortality patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors. 86
Glycosylated hemoglobin and the risk of periprocedural myocardial infarction in non-diabetic patients 86
Impact of Diabetes on Homocysteine Levels and Its Relationship with Coronary Artery Disease: A Single-Centre Cohort Study 86
Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. 86
A meta-analytic overview of thrombectomy during primary angioplasty 85
Redefining the success of mechanical reperfusion: ST-segment resolution 85
Homocysteine levels and platelet reactivity in coronary artery disease patients treated with ticagrelor 85
Mechanical prevention of distal embolization: Rationale and trial results 84
Platelet HPA-1 a/HPA-1 b polymorphism and the risk of periprocedural myocardial infarction in patients undergoing elective PCI. 84
Impact of metabolic syndrome on mean platelet volume and its relationship with coronary artery disease 84
Advances in antithrombotic therapy as adjunct to reperfusion therapies for ST-segment elevation myocardial infarction 83
Bivalirudin as compared to unfractionated heparin in patients undergoing percutaneous coronary revascularization: A meta-analysis of 22 randomized trials 83
Long-term outcome of drug-eluting stents compared with bare metal stents in st-segment elevation myocardial infarction results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in primary angioplasty (paseo) randomized trial (Retraction in: Circulation (2010) 121:8 (e228)) 83
Immature platelet fraction and the extent of coronary artery disease: a single centre study. 83
Adjunctive benefits from low-molecular-weight heparins as compared to unfractionated heparin among patients with ST-segment elevation myocardial infarction treated with thrombolysis. A meta-analysis of the randomized trials 83
Impact of diabetes on uric acid and its relationship with the extent of coronary artery disease and platelet aggregation: a single-centre cohort study. 82
Platelet reactivity in patients with impaired renal function receiving dual antiplatelet therapy with clopidogrel or ticagrelor 82
Dual Versus Single Antiplatelet Regimen With or Without Anticoagulation in Transcatheter Aortic Valve Replacement: Indirect Comparison and Meta-analysis 82
Cholecalciferol levels, inflammation and leukocytes parameters: Results from a large single-centre cohort of patients 82
Balloon angioplasty or BMS? 81
Radial vs femoral approach in acute coronary syndromes: A meta-analysis of randomized trials 81
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease. 81
Antithrombotic Therapy After Percutaneous Aortic Valve Implantation: Large Gaps for a Matter of Extreme Importance. Response 80
Gender differences in platelet reactivity in diabetic patients receiving dual antiplatelet therapy 80
Aging, impaired myocardial perfusion and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty 78
Platelet distribution width and the risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention 78
Benefits from new ADP-antagonists as compared to clopidogrel in patients with stable angina or acute coronary syndrome undergoing invasive management: a meta-analysis of randomized trials. 78
Duration of dual antiplatelet therapy and outcome in patients with acute coronary syndrome undergoing percutaneous revascularization: A meta-analysis of 11 randomized trials 78
Benefits from intracoronary as compared to intravenous abciximab administration for STEMI patients undergoing primary angioplasty: a meta-analysis of 8 randomized trials. 77
Mean platelet volume and the risk of periprocedural myocardial infarction in patients undergoing coronary angioplasty 77
Comprehensive meta-analysis of radial vs femoral approach in primary angioplasty for STEMI. 77
Impact of diabetes on fibrinogen levels and its relationship with platelet reactivity and coronary artery disease: A single-centre study 77
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease 77
Haemoglobin levels do not correlate with the extent of coronary artery disease: results from a large cohort study. 77
Preprocedural β-Blockers in the Functional Assessment of Intermediate Coronary Lesions by Instantaneous Wave-Free Ratio 77
High-Density Lipoproteins and Coronary Artery Disease: A Single-Center Cohort Study 77
LOW-DOSE DOBUTAMINE ECHOCARDIOGRAPHY PREDICTING FUNCTIONAL RECOVERY AFTER CORONARY REVASCULARIZATION 76
Absence of seasonal variation in myocardial perfusion, enzymatic infarct size, and mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty 76
Immature platelet fraction and the extent of coronary artery disease: A single centre study 76
Time-related impact of distal embolisation on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation. 76
Impact of long-term therapy with acetylsalicylic acid on immature platelet count: a single-centre cohort study 76
Impact of time from symptom onset to drug administration on outcome in patients undergoing glycoprotein IIb-IIIa facilitated primary angioplasty (from the EGYPT Cooperation) 75
Optical coherence tomography guidance during bioresorbable vascular scaffold implantation 75
Prevalence and predictors of high-on treatment platelet reactivity with ticagrelor in ACS patients undergoing stent implantation 75
Impact of anticoagulation strategy with bivalirudin or heparin on nonaccess site bleeding in percutaneous coronary interventions: A meta-analysis of randomized trials 75
Left ventricular angiography and other angiocardiographic techniques 74
Adjunctive antithrombotic therapy during Primary PCI 74
A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale 74
Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials 74
Platelet Larger Cell Ratio and High-on Treatment Platelet Reactivity During Dual Antiplatelet Therapy 74
Prevalence and predictors of high-on treatment platelet reactivity with ticagrelor in ACS patients undergoing stent implantation. 74
Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials 74
Totale 8.742
Salva come PNG Salva come JPEG
Categoria #
all - tutte 145.772
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 145.772
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.246 0 0 0 0 0 50 344 6 388 35 395 28
2021/20222.083 72 54 302 135 200 8 163 35 155 60 385 514
2022/20234.395 412 147 211 54 246 262 81 193 2.640 8 87 54
2023/20241.236 65 71 78 18 279 2 225 20 3 9 188 278
2024/20252.968 55 29 98 21 70 387 280 234 936 350 62 446
2025/20264.907 364 374 1.088 1.920 737 424 0 0 0 0 0 0
Totale 23.793